Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.60861963 |
2 | L-phenylalanine catabolic process (GO:0006559) | 6.60861963 |
3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.30013542 |
4 | L-phenylalanine metabolic process (GO:0006558) | 6.30013542 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 5.97099960 |
6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.72917604 |
7 | indole-containing compound catabolic process (GO:0042436) | 5.41271109 |
8 | indolalkylamine catabolic process (GO:0046218) | 5.41271109 |
9 | tryptophan catabolic process (GO:0006569) | 5.41271109 |
10 | urea metabolic process (GO:0019627) | 5.33776791 |
11 | urea cycle (GO:0000050) | 5.33776791 |
12 | alpha-linolenic acid metabolic process (GO:0036109) | 5.33239811 |
13 | bile acid biosynthetic process (GO:0006699) | 5.26863765 |
14 | complement activation, alternative pathway (GO:0006957) | 5.23185151 |
15 | kynurenine metabolic process (GO:0070189) | 5.20992190 |
16 | protein carboxylation (GO:0018214) | 5.19639419 |
17 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.19639419 |
18 | tryptophan metabolic process (GO:0006568) | 5.13863463 |
19 | regulation of protein activation cascade (GO:2000257) | 5.02235472 |
20 | nitrogen cycle metabolic process (GO:0071941) | 4.91192038 |
21 | high-density lipoprotein particle remodeling (GO:0034375) | 4.91087031 |
22 | glyoxylate metabolic process (GO:0046487) | 4.86515825 |
23 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.86444677 |
24 | negative regulation of fibrinolysis (GO:0051918) | 4.86029957 |
25 | regulation of complement activation (GO:0030449) | 4.75931218 |
26 | sulfur amino acid catabolic process (GO:0000098) | 4.73518684 |
27 | regulation of fibrinolysis (GO:0051917) | 4.72643101 |
28 | bile acid metabolic process (GO:0008206) | 4.68324029 |
29 | regulation of triglyceride catabolic process (GO:0010896) | 4.54847110 |
30 | reverse cholesterol transport (GO:0043691) | 4.51680000 |
31 | cysteine metabolic process (GO:0006534) | 4.49348278 |
32 | phospholipid efflux (GO:0033700) | 4.45992775 |
33 | regulation of cholesterol esterification (GO:0010872) | 4.35122953 |
34 | serine family amino acid catabolic process (GO:0009071) | 4.28887538 |
35 | aromatic amino acid family metabolic process (GO:0009072) | 4.28203189 |
36 | acylglycerol homeostasis (GO:0055090) | 4.26185145 |
37 | triglyceride homeostasis (GO:0070328) | 4.26185145 |
38 | glycosphingolipid catabolic process (GO:0046479) | 4.23271036 |
39 | tyrosine metabolic process (GO:0006570) | 4.22249550 |
40 | protein-lipid complex remodeling (GO:0034368) | 4.18515049 |
41 | macromolecular complex remodeling (GO:0034367) | 4.18515049 |
42 | plasma lipoprotein particle remodeling (GO:0034369) | 4.18515049 |
43 | homocysteine metabolic process (GO:0050667) | 4.18484872 |
44 | epoxygenase P450 pathway (GO:0019373) | 4.16885463 |
45 | complement activation, classical pathway (GO:0006958) | 4.15371226 |
46 | regulation of macrophage chemotaxis (GO:0010758) | 4.09792705 |
47 | complement activation (GO:0006956) | 4.06599816 |
48 | plasma lipoprotein particle clearance (GO:0034381) | 4.06349480 |
49 | * bile acid and bile salt transport (GO:0015721) | 4.05075742 |
50 | negative regulation of sterol transport (GO:0032372) | 4.01161077 |
51 | negative regulation of cholesterol transport (GO:0032375) | 4.01161077 |
52 | lysine catabolic process (GO:0006554) | 4.00867207 |
53 | lysine metabolic process (GO:0006553) | 4.00867207 |
54 | alpha-amino acid catabolic process (GO:1901606) | 4.00613939 |
55 | amino-acid betaine metabolic process (GO:0006577) | 3.99997857 |
56 | cholesterol efflux (GO:0033344) | 3.97209851 |
57 | regulation of apoptotic cell clearance (GO:2000425) | 3.90306358 |
58 | negative regulation of lipase activity (GO:0060192) | 3.89783434 |
59 | cellular biogenic amine catabolic process (GO:0042402) | 3.88634581 |
60 | amine catabolic process (GO:0009310) | 3.88634581 |
61 | phospholipid homeostasis (GO:0055091) | 3.86063788 |
62 | cellular ketone body metabolic process (GO:0046950) | 3.85017720 |
63 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.84883346 |
64 | glycolipid catabolic process (GO:0019377) | 3.84587225 |
65 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.83734338 |
66 | indolalkylamine metabolic process (GO:0006586) | 3.81165123 |
67 | protein activation cascade (GO:0072376) | 3.80556378 |
68 | cellular modified amino acid catabolic process (GO:0042219) | 3.78882267 |
69 | cellular glucuronidation (GO:0052695) | 3.78009608 |
70 | fibrinolysis (GO:0042730) | 3.75022494 |
71 | regulation of mononuclear cell migration (GO:0071675) | 3.74142510 |
72 | coenzyme catabolic process (GO:0009109) | 3.73309127 |
73 | plasma lipoprotein particle assembly (GO:0034377) | 3.73116517 |
74 | cellular amino acid catabolic process (GO:0009063) | 3.72497247 |
75 | oligosaccharide catabolic process (GO:0009313) | 3.66110378 |
76 | glutamate metabolic process (GO:0006536) | 3.65777266 |
77 | ethanol oxidation (GO:0006069) | 3.65759012 |
78 | imidazole-containing compound metabolic process (GO:0052803) | 3.64161015 |
79 | positive regulation of lipid catabolic process (GO:0050996) | 3.60673993 |
80 | omega-hydroxylase P450 pathway (GO:0097267) | 3.57486632 |
81 | low-density lipoprotein particle remodeling (GO:0034374) | 3.56880897 |
82 | benzene-containing compound metabolic process (GO:0042537) | 3.54373192 |
83 | protein-lipid complex assembly (GO:0065005) | 3.53144112 |
84 | cholesterol homeostasis (GO:0042632) | 3.50800644 |
85 | arginine metabolic process (GO:0006525) | 3.48520184 |
86 | drug catabolic process (GO:0042737) | 3.48088687 |
87 | cytolysis (GO:0019835) | 3.47784759 |
88 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.47173350 |
89 | sterol homeostasis (GO:0055092) | 3.45708022 |
90 | positive regulation of chemokine secretion (GO:0090197) | 3.42908576 |
91 | exogenous drug catabolic process (GO:0042738) | 3.41284276 |
92 | blood coagulation, intrinsic pathway (GO:0007597) | 3.39574423 |
93 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.39528161 |
94 | N-acetylneuraminate metabolic process (GO:0006054) | 3.39369713 |
95 | glycine metabolic process (GO:0006544) | 3.39222758 |
96 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.38189246 |
97 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.38189246 |
98 | short-chain fatty acid metabolic process (GO:0046459) | 3.36971526 |
99 | organic acid catabolic process (GO:0016054) | 3.36125646 |
100 | carboxylic acid catabolic process (GO:0046395) | 3.36125646 |
101 | ceramide catabolic process (GO:0046514) | 3.35662137 |
102 | virion attachment to host cell (GO:0019062) | 3.32985691 |
103 | adhesion of symbiont to host cell (GO:0044650) | 3.32985691 |
104 | glucuronate metabolic process (GO:0019585) | 3.32931306 |
105 | uronic acid metabolic process (GO:0006063) | 3.32931306 |
106 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.30705426 |
107 | ketone body metabolic process (GO:1902224) | 3.29692382 |
108 | plasma lipoprotein particle organization (GO:0071827) | 3.29463094 |
109 | acetyl-CoA metabolic process (GO:0006084) | 3.27785569 |
110 | serine family amino acid metabolic process (GO:0009069) | 3.26092871 |
111 | regulation of bile acid biosynthetic process (GO:0070857) | 3.25497491 |
112 | monocarboxylic acid catabolic process (GO:0072329) | 3.25284979 |
113 | cofactor catabolic process (GO:0051187) | 3.25176139 |
114 | macrophage activation involved in immune response (GO:0002281) | 3.24381841 |
115 | fatty acid oxidation (GO:0019395) | 3.23233951 |
116 | flavonoid metabolic process (GO:0009812) | 3.23052802 |
117 | fatty acid beta-oxidation (GO:0006635) | 3.22061755 |
118 | regulation of hypersensitivity (GO:0002883) | 3.21780833 |
119 | adenosine receptor signaling pathway (GO:0001973) | 3.21690821 |
120 | lipoprotein metabolic process (GO:0042157) | 3.21380544 |
121 | adhesion of symbiont to host (GO:0044406) | 3.20656618 |
122 | cellular response to ethanol (GO:0071361) | 3.19192904 |
123 | amino sugar catabolic process (GO:0046348) | 3.17592018 |
124 | detection of molecule of bacterial origin (GO:0032490) | 3.10629267 |
125 | apoptotic cell clearance (GO:0043277) | 3.07194107 |
126 | protein-lipid complex subunit organization (GO:0071825) | 3.07067994 |
127 | angiotensin maturation (GO:0002003) | 3.06630988 |
128 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.05900602 |
129 | positive regulation of phagocytosis (GO:0050766) | 3.05129334 |
130 | positive regulation of cholesterol efflux (GO:0010875) | 3.04380166 |
131 | regulation of cholesterol storage (GO:0010885) | 3.00476305 |
132 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.98376934 |
133 | regulation of chemokine secretion (GO:0090196) | 2.98042383 |
134 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.90260155 |
135 | positive regulation of cholesterol transport (GO:0032376) | 2.88913887 |
136 | positive regulation of sterol transport (GO:0032373) | 2.88913887 |
137 | response to thyroid hormone (GO:0097066) | 2.84930234 |
138 | cellular response to cadmium ion (GO:0071276) | 2.83491825 |
139 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.82485483 |
140 | acute-phase response (GO:0006953) | 2.82043473 |
141 | negative regulation of hemostasis (GO:1900047) | 2.79779331 |
142 | negative regulation of blood coagulation (GO:0030195) | 2.79779331 |
143 | barbed-end actin filament capping (GO:0051016) | 2.76788871 |
144 | negative regulation of interleukin-12 production (GO:0032695) | 2.73262765 |
145 | positive regulation of antigen processing and presentation (GO:0002579) | 2.72801470 |
146 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.67778564 |
147 | positive regulation of mast cell degranulation (GO:0043306) | 2.67778564 |
148 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.67694685 |
149 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.66988766 |
150 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.66425159 |
151 | mannose metabolic process (GO:0006013) | 2.65778758 |
152 | drug metabolic process (GO:0017144) | 2.64811430 |
153 | immunoglobulin mediated immune response (GO:0016064) | 2.64712630 |
154 | positive regulation of leukocyte degranulation (GO:0043302) | 2.63808950 |
155 | negative regulation of granulocyte differentiation (GO:0030853) | 2.63094960 |
156 | negative regulation of coagulation (GO:0050819) | 2.61770852 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.69798296 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.98950883 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.07591113 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.73472016 |
5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.49105104 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.63087806 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.55097334 |
8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.73918023 |
9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.67673101 |
10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.83850337 |
11 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.26119883 |
12 | GATA1_22025678_ChIP-Seq_K562_Human | 1.98370033 |
13 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.87645890 |
14 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.81742717 |
15 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.78618081 |
16 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.78613677 |
17 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.74293168 |
18 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.68089686 |
19 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.65606706 |
20 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.61179095 |
21 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.59657112 |
22 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.55007087 |
23 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.52829721 |
24 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.52789879 |
25 | * MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.51673737 |
26 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.50458058 |
27 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.45056734 |
28 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.38321344 |
29 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.34678738 |
30 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.27752456 |
31 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.27151451 |
32 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.27145338 |
33 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.25942734 |
34 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.25418223 |
35 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.24386741 |
36 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.22684184 |
37 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.21933659 |
38 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.21660433 |
39 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.18722603 |
40 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.18057621 |
41 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.16527171 |
42 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.15451333 |
43 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.11135594 |
44 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.10719561 |
45 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.10473275 |
46 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.07695924 |
47 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.03658015 |
48 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.98223594 |
49 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.97325401 |
50 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.97018693 |
51 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.96973783 |
52 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.95580272 |
53 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.95261368 |
54 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.95247230 |
55 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94587638 |
56 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.93940320 |
57 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93403288 |
58 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.92192844 |
59 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.91814148 |
60 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91757542 |
61 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.90685721 |
62 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.90535648 |
63 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89703050 |
64 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.89663073 |
65 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89569378 |
66 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.89407744 |
67 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.88905929 |
68 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.88684566 |
69 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.87741079 |
70 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.87727046 |
71 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.87215773 |
72 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.86975621 |
73 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86621717 |
74 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.86312752 |
75 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.85916650 |
76 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.84701983 |
77 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.83896560 |
78 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.83271570 |
79 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.83122344 |
80 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.82908773 |
81 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.82717945 |
82 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82375665 |
83 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.81597496 |
84 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.81097221 |
85 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.81094725 |
86 | * GATA1_19941826_ChIP-Seq_K562_Human | 0.80608384 |
87 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.79439243 |
88 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.78291535 |
89 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78046478 |
90 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77742498 |
91 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.77616058 |
92 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.77114166 |
93 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.76251262 |
94 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.74821556 |
95 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.74531206 |
96 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.74531206 |
97 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.73217763 |
98 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73177073 |
99 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.72740923 |
100 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.71711830 |
101 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.69962998 |
102 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.69941979 |
103 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69358582 |
104 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.67606111 |
105 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.67222714 |
106 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.66534246 |
107 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.64574038 |
108 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.63738005 |
109 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.62787620 |
110 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.62272902 |
111 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.61581390 |
112 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.60359025 |
113 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.59054698 |
114 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.57631822 |
115 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.57163554 |
116 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.56939661 |
117 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.56939661 |
118 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.55243993 |
119 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.52833117 |
120 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.51531096 |
121 | CJUN_26792858_Chip-Seq_BT549_Human | 0.51397429 |
122 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.51183965 |
123 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.50827514 |
124 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.50652118 |
125 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.50452734 |
126 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.50231200 |
127 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.49905388 |
128 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.49056647 |
129 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.47741964 |
130 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.46536433 |
131 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.45903870 |
132 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.45685009 |
133 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.44542451 |
134 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.44195024 |
135 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.43274428 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.00169163 |
2 | MP0005360_urolithiasis | 6.52950084 |
3 | MP0005085_abnormal_gallbladder_physiolo | 6.01210490 |
4 | MP0005365_abnormal_bile_salt | 5.39461157 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.44544976 |
6 | MP0003191_abnormal_cellular_cholesterol | 4.11955526 |
7 | MP0003252_abnormal_bile_duct | 4.09465459 |
8 | MP0009840_abnormal_foam_cell | 3.59466594 |
9 | MP0010329_abnormal_lipoprotein_level | 3.34143909 |
10 | MP0003806_abnormal_nucleotide_metabolis | 3.05613043 |
11 | MP0005332_abnormal_amino_acid | 2.33666902 |
12 | MP0005083_abnormal_biliary_tract | 2.26243777 |
13 | MP0001666_abnormal_nutrient_absorption | 2.20987394 |
14 | MP0000609_abnormal_liver_physiology | 2.16669567 |
15 | MP0002118_abnormal_lipid_homeostasis | 2.05809917 |
16 | MP0004019_abnormal_vitamin_homeostasis | 1.98177812 |
17 | MP0003195_calcinosis | 1.97666401 |
18 | MP0005670_abnormal_white_adipose | 1.96250524 |
19 | MP0003329_amyloid_beta_deposits | 1.91864430 |
20 | MP0009785_altered_susceptibility_to | 1.91440276 |
21 | MP0002148_abnormal_hypersensitivity_rea | 1.81868698 |
22 | MP0006082_CNS_inflammation | 1.80234640 |
23 | MP0005387_immune_system_phenotype | 1.78852829 |
24 | MP0001790_abnormal_immune_system | 1.78852829 |
25 | MP0002138_abnormal_hepatobiliary_system | 1.72933022 |
26 | MP0002998_abnormal_bone_remodeling | 1.70473691 |
27 | MP0000685_abnormal_immune_system | 1.67268184 |
28 | MP0005319_abnormal_enzyme/_coenzyme | 1.62709390 |
29 | MP0005058_abnormal_lysosome_morphology | 1.61664086 |
30 | MP0003690_abnormal_glial_cell | 1.61607025 |
31 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.51363064 |
32 | MP0003868_abnormal_feces_composition | 1.49247604 |
33 | MP0002254_reproductive_system_inflammat | 1.47775255 |
34 | MP0010368_abnormal_lymphatic_system | 1.42726144 |
35 | MP0000920_abnormal_myelination | 1.41605862 |
36 | MP0001764_abnormal_homeostasis | 1.37246755 |
37 | MP0005000_abnormal_immune_tolerance | 1.35086877 |
38 | MP0005464_abnormal_platelet_physiology | 1.34333355 |
39 | MP0009278_abnormal_bone_marrow | 1.32740136 |
40 | MP0003724_increased_susceptibility_to | 1.30130497 |
41 | MP0005397_hematopoietic_system_phenotyp | 1.27105607 |
42 | MP0001545_abnormal_hematopoietic_system | 1.27105607 |
43 | MP0003879_abnormal_hair_cell | 1.26881735 |
44 | MP0002452_abnormal_antigen_presenting | 1.24179250 |
45 | MP0005647_abnormal_sex_gland | 1.22691735 |
46 | MP0009643_abnormal_urine_homeostasis | 1.21346619 |
47 | MP0008469_abnormal_protein_level | 1.20157604 |
48 | MP0003705_abnormal_hypodermis_morpholog | 1.19423306 |
49 | MP0004130_abnormal_muscle_cell | 1.18851030 |
50 | MP0002723_abnormal_immune_serum | 1.15709535 |
51 | MP0000598_abnormal_liver_morphology | 1.15557157 |
52 | MP0003075_altered_response_to | 1.14616759 |
53 | MP0009697_abnormal_copulation | 1.13251035 |
54 | MP0005451_abnormal_body_composition | 1.12982769 |
55 | MP0009763_increased_sensitivity_to | 1.08793149 |
56 | MP0005167_abnormal_blood-brain_barrier | 1.08137401 |
57 | MP0005666_abnormal_adipose_tissue | 1.07827752 |
58 | MP0003828_pulmonary_edema | 1.07384780 |
59 | MP0001800_abnormal_humoral_immune | 1.05041450 |
60 | MP0009764_decreased_sensitivity_to | 1.04941300 |
61 | MP0010155_abnormal_intestine_physiology | 1.03399370 |
62 | MP0003172_abnormal_lysosome_physiology | 1.03065647 |
63 | MP0003183_abnormal_peptide_metabolism | 1.01759040 |
64 | MP0000604_amyloidosis | 1.00627923 |
65 | MP0003656_abnormal_erythrocyte_physiolo | 1.00352023 |
66 | MP0002928_abnormal_bile_duct | 0.97787724 |
67 | MP0002971_abnormal_brown_adipose | 0.93396070 |
68 | MP0003011_delayed_dark_adaptation | 0.92314160 |
69 | MP0005310_abnormal_salivary_gland | 0.91684517 |
70 | MP0004510_myositis | 0.91679461 |
71 | MP0009642_abnormal_blood_homeostasis | 0.90286819 |
72 | MP0005334_abnormal_fat_pad | 0.88888135 |
73 | MP0001819_abnormal_immune_cell | 0.87788206 |
74 | MP0002420_abnormal_adaptive_immunity | 0.86155637 |
75 | MP0003300_gastrointestinal_ulcer | 0.86148598 |
76 | MP0004947_skin_inflammation | 0.85373183 |
77 | MP0003186_abnormal_redox_activity | 0.84296499 |
78 | MP0003634_abnormal_glial_cell | 0.84136369 |
79 | MP0005535_abnormal_body_temperature | 0.83501924 |
80 | MP0002405_respiratory_system_inflammati | 0.82832789 |
81 | MP0003436_decreased_susceptibility_to | 0.82738552 |
82 | MP0005166_decreased_susceptibility_to | 0.82673541 |
83 | MP0003303_peritoneal_inflammation | 0.81361864 |
84 | MP0003448_altered_tumor_morphology | 0.79852886 |
85 | MP0002419_abnormal_innate_immunity | 0.79307761 |
86 | MP0000858_altered_metastatic_potential | 0.79221981 |
87 | MP0004185_abnormal_adipocyte_glucose | 0.79194055 |
88 | MP0003632_abnormal_nervous_system | 0.78748149 |
89 | MP0004883_abnormal_blood_vessel | 0.77519936 |
90 | MP0000249_abnormal_blood_vessel | 0.74958354 |
91 | MP0003453_abnormal_keratinocyte_physiol | 0.74915228 |
92 | MP0009333_abnormal_splenocyte_physiolog | 0.73259133 |
93 | MP0003279_aneurysm | 0.72883792 |
94 | MP0001835_abnormal_antigen_presentation | 0.72870223 |
95 | MP0002090_abnormal_vision | 0.72342871 |
96 | MP0008874_decreased_physiological_sensi | 0.71240975 |
97 | MP0001756_abnormal_urination | 0.70771910 |
98 | MP0002078_abnormal_glucose_homeostasis | 0.69462865 |
99 | MP0005376_homeostasis/metabolism_phenot | 0.69332033 |
100 | MP0008260_abnormal_autophagy | 0.69319931 |
101 | MP0008873_increased_physiological_sensi | 0.68168817 |
102 | MP0002896_abnormal_bone_mineralization | 0.67531511 |
103 | MP0009765_abnormal_xenobiotic_induced | 0.66917123 |
104 | MP0003638_abnormal_response/metabolism_ | 0.64418013 |
105 | MP0008004_abnormal_stomach_pH | 0.64358715 |
106 | MP0009053_abnormal_anal_canal | 0.64096426 |
107 | MP0001533_abnormal_skeleton_physiology | 0.63837339 |
108 | MP0001853_heart_inflammation | 0.62631513 |
109 | MP0001986_abnormal_taste_sensitivity | 0.61450210 |
110 | MP0001845_abnormal_inflammatory_respons | 0.60979234 |
111 | MP0009115_abnormal_fat_cell | 0.60972803 |
112 | MP0005636_abnormal_mineral_homeostasis | 0.60940231 |
113 | MP0002136_abnormal_kidney_physiology | 0.60760802 |
114 | MP0009384_cardiac_valve_regurgitation | 0.58836747 |
115 | MP0005671_abnormal_response_to | 0.58427174 |
116 | MP0005084_abnormal_gallbladder_morpholo | 0.58244894 |
117 | MP0005448_abnormal_energy_balance | 0.54015764 |
118 | MP0000343_altered_response_to | 0.53820910 |
119 | MP0005164_abnormal_response_to | 0.53568759 |
120 | MP0001915_intracranial_hemorrhage | 0.53425716 |
121 | MP0005375_adipose_tissue_phenotype | 0.52832842 |
122 | MP0000639_abnormal_adrenal_gland | 0.51508268 |
123 | MP0004782_abnormal_surfactant_physiolog | 0.51180766 |
124 | MP0002876_abnormal_thyroid_physiology | 0.50554884 |
125 | MP0001851_eye_inflammation | 0.50143828 |
126 | MP0005165_increased_susceptibility_to | 0.47332469 |
127 | MP0005408_hypopigmentation | 0.46562370 |
128 | MP0005025_abnormal_response_to | 0.46474879 |
129 | MP0000230_abnormal_systemic_arterial | 0.45302693 |
130 | MP0005595_abnormal_vascular_smooth | 0.41930742 |
131 | MP0005023_abnormal_wound_healing | 0.41928783 |
132 | MP0003633_abnormal_nervous_system | 0.40994512 |
133 | MP0000767_abnormal_smooth_muscle | 0.40248367 |
134 | MP0005220_abnormal_exocrine_pancreas | 0.38921903 |
135 | MP0002168_other_aberrant_phenotype | 0.38330131 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Complement deficiency (HP:0004431) | 7.58440146 |
2 | Systemic lupus erythematosus (HP:0002725) | 6.50312970 |
3 | Deep venous thrombosis (HP:0002625) | 6.46102009 |
4 | Intrahepatic cholestasis (HP:0001406) | 6.12302151 |
5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.08545420 |
6 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.70815524 |
7 | Prolonged partial thromboplastin time (HP:0003645) | 5.69120033 |
8 | Abnormality of complement system (HP:0005339) | 5.55814031 |
9 | Glomerulonephritis (HP:0000099) | 5.53929065 |
10 | Xanthomatosis (HP:0000991) | 5.48073909 |
11 | Hypobetalipoproteinemia (HP:0003563) | 5.08271733 |
12 | Hyperlipoproteinemia (HP:0010980) | 4.86679434 |
13 | Vacuolated lymphocytes (HP:0001922) | 4.85130416 |
14 | Joint hemorrhage (HP:0005261) | 4.51521013 |
15 | Increased cerebral lipofuscin (HP:0011813) | 4.42586776 |
16 | Hypolipoproteinemia (HP:0010981) | 4.14431782 |
17 | Mutism (HP:0002300) | 4.01433056 |
18 | Hyperammonemia (HP:0001987) | 3.99954922 |
19 | Hypoalphalipoproteinemia (HP:0003233) | 3.97903859 |
20 | Epidermoid cyst (HP:0200040) | 3.90205980 |
21 | Abnormality of the common coagulation pathway (HP:0010990) | 3.85076275 |
22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.84007363 |
23 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.69821295 |
24 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.66894927 |
25 | Ketosis (HP:0001946) | 3.65801853 |
26 | Hyperglycinemia (HP:0002154) | 3.61971376 |
27 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.54406208 |
28 | Neurofibrillary tangles (HP:0002185) | 3.47405606 |
29 | Abnormality of methionine metabolism (HP:0010901) | 3.46112285 |
30 | Hyperglycinuria (HP:0003108) | 3.43781308 |
31 | Myocardial infarction (HP:0001658) | 3.42348679 |
32 | Disinhibition (HP:0000734) | 3.40906121 |
33 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.40332883 |
34 | Abnormality of macrophages (HP:0004311) | 3.39317020 |
35 | Hypoglycemic coma (HP:0001325) | 3.39260792 |
36 | Fat malabsorption (HP:0002630) | 3.37318465 |
37 | Abnormality of the intrinsic pathway (HP:0010989) | 3.32546062 |
38 | Abnormality of glycine metabolism (HP:0010895) | 3.32123303 |
39 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.32123303 |
40 | Nephritis (HP:0000123) | 3.27623489 |
41 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.26958932 |
42 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.26958932 |
43 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.26958932 |
44 | Hypercholesterolemia (HP:0003124) | 3.24254466 |
45 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.20573644 |
46 | Mucopolysacchariduria (HP:0008155) | 3.20573644 |
47 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.12016842 |
48 | Eczematoid dermatitis (HP:0000976) | 3.09589044 |
49 | Loss of speech (HP:0002371) | 3.08991278 |
50 | Conjugated hyperbilirubinemia (HP:0002908) | 3.04492501 |
51 | Purpura (HP:0000979) | 2.99802502 |
52 | Amyloidosis (HP:0011034) | 2.95719412 |
53 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.93093566 |
54 | Recurrent abscess formation (HP:0002722) | 2.82888229 |
55 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.80227425 |
56 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.79943295 |
57 | Retinal atrophy (HP:0001105) | 2.74687426 |
58 | Spontaneous hematomas (HP:0007420) | 2.71056637 |
59 | Recurrent bacterial skin infections (HP:0005406) | 2.67387774 |
60 | Hyperbilirubinemia (HP:0002904) | 2.61060264 |
61 | Ketoacidosis (HP:0001993) | 2.60051877 |
62 | Skin nodule (HP:0200036) | 2.58830975 |
63 | Abnormality of nucleobase metabolism (HP:0010932) | 2.57572728 |
64 | Axonal loss (HP:0003447) | 2.56143442 |
65 | Hepatocellular carcinoma (HP:0001402) | 2.54955239 |
66 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.52362191 |
67 | Delayed CNS myelination (HP:0002188) | 2.51909104 |
68 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.49245870 |
69 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.47558688 |
70 | Steatorrhea (HP:0002570) | 2.46191065 |
71 | Cerebral inclusion bodies (HP:0100314) | 2.44203152 |
72 | Abnormality of serum amino acid levels (HP:0003112) | 2.42750202 |
73 | Upper motor neuron abnormality (HP:0002127) | 2.40241182 |
74 | Sensorimotor neuropathy (HP:0007141) | 2.37038530 |
75 | Vascular calcification (HP:0004934) | 2.36106503 |
76 | Neuronal loss in central nervous system (HP:0002529) | 2.35372330 |
77 | Mitral stenosis (HP:0001718) | 2.34222704 |
78 | Hemorrhage of the eye (HP:0011885) | 2.33971922 |
79 | Abnormality of purine metabolism (HP:0004352) | 2.30350670 |
80 | Esophageal varix (HP:0002040) | 2.29900049 |
81 | Spontaneous abortion (HP:0005268) | 2.26304452 |
82 | Hypochromic microcytic anemia (HP:0004840) | 2.23928102 |
83 | Abnormality of the periventricular white matter (HP:0002518) | 2.22000986 |
84 | Metabolic acidosis (HP:0001942) | 2.21753457 |
85 | Mediastinal lymphadenopathy (HP:0100721) | 2.21637093 |
86 | Hypoglycemic seizures (HP:0002173) | 2.20579934 |
87 | Increased serum ferritin (HP:0003281) | 2.19728241 |
88 | Pathologic fracture (HP:0002756) | 2.18259906 |
89 | Gingivitis (HP:0000230) | 2.16032519 |
90 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.14121387 |
91 | Dicarboxylic aciduria (HP:0003215) | 2.14121387 |
92 | Abnormality of glycolipid metabolism (HP:0010969) | 2.12929210 |
93 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.12929210 |
94 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.12929210 |
95 | Gingival bleeding (HP:0000225) | 2.12018415 |
96 | Peripheral demyelination (HP:0011096) | 2.11846480 |
97 | Agnosia (HP:0010524) | 2.10688918 |
98 | Cardiovascular calcification (HP:0011915) | 2.10113417 |
99 | Menorrhagia (HP:0000132) | 2.09562579 |
100 | Dementia (HP:0000726) | 2.06382525 |
101 | Malnutrition (HP:0004395) | 2.00128330 |
102 | Spastic diplegia (HP:0001264) | 1.98534426 |
103 | Irritability (HP:0000737) | 1.97998849 |
104 | Nuclear cataract (HP:0100018) | 1.96418098 |
105 | J-shaped sella turcica (HP:0002680) | 1.96403393 |
106 | Abnormal gallbladder morphology (HP:0012437) | 1.95173531 |
107 | Abnormality of proline metabolism (HP:0010907) | 1.94352922 |
108 | Hydroxyprolinuria (HP:0003080) | 1.94352922 |
109 | Thrombophlebitis (HP:0004418) | 1.93266638 |
110 | Cholelithiasis (HP:0001081) | 1.92955962 |
111 | Bone pain (HP:0002653) | 1.91574568 |
112 | Autoimmune thrombocytopenia (HP:0001973) | 1.91310048 |
113 | Lethargy (HP:0001254) | 1.91085836 |
114 | Progressive visual loss (HP:0000529) | 1.89631112 |
115 | Neonatal onset (HP:0003623) | 1.88963345 |
116 | Pancreatitis (HP:0001733) | 1.88139338 |
117 | Polycythemia (HP:0001901) | 1.87406623 |
118 | Asymmetric septal hypertrophy (HP:0001670) | 1.86700079 |
119 | Status epilepticus (HP:0002133) | 1.86330642 |
120 | Cerebral aneurysm (HP:0004944) | 1.86309871 |
121 | Dysostosis multiplex (HP:0000943) | 1.86235236 |
122 | Stroke (HP:0001297) | 1.86014599 |
123 | Abnormal gallbladder physiology (HP:0012438) | 1.85457439 |
124 | Cholecystitis (HP:0001082) | 1.85457439 |
125 | Recurrent skin infections (HP:0001581) | 1.85434023 |
126 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.84407004 |
127 | Apathy (HP:0000741) | 1.84153847 |
128 | Thoracic kyphosis (HP:0002942) | 1.83205810 |
129 | Gout (HP:0001997) | 1.82907127 |
130 | Conjunctival telangiectasia (HP:0000524) | 1.82771419 |
131 | Colitis (HP:0002583) | 1.82766317 |
132 | Acanthocytosis (HP:0001927) | 1.82490989 |
133 | Protuberant abdomen (HP:0001538) | 1.80752605 |
134 | Arterial tortuosity (HP:0005116) | 1.80459260 |
135 | Diminished motivation (HP:0000745) | 1.80335386 |
136 | Epistaxis (HP:0000421) | 1.80121147 |
137 | Abnormality of iron homeostasis (HP:0011031) | 1.79573468 |
138 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.78887436 |
139 | Pulmonary embolism (HP:0002204) | 1.77563792 |
140 | Inappropriate behavior (HP:0000719) | 1.77459961 |
141 | Cardiomegaly (HP:0001640) | 1.77187386 |
142 | Increased CSF protein (HP:0002922) | 1.77027832 |
143 | Abnormal platelet function (HP:0011869) | 1.76841720 |
144 | Impaired platelet aggregation (HP:0003540) | 1.76841720 |
145 | Abnormality of the Achilles tendon (HP:0005109) | 1.76827725 |
146 | Interstitial pulmonary disease (HP:0006530) | 1.76634589 |
147 | Metaphyseal irregularity (HP:0003025) | 1.75680752 |
148 | Late onset (HP:0003584) | 1.75601429 |
149 | Hematochezia (HP:0002573) | 1.75260719 |
150 | Disproportionate tall stature (HP:0001519) | 1.75072621 |
151 | Hypophosphatemia (HP:0002148) | 1.73966401 |
152 | Orchitis (HP:0100796) | 1.73116274 |
153 | Personality changes (HP:0000751) | 1.68338375 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TGFBR2 | 6.54515227 |
2 | MAPK15 | 4.14864336 |
3 | BCKDK | 3.59485385 |
4 | ERN1 | 3.40307933 |
5 | SIK1 | 2.77163361 |
6 | CSF1R | 2.60461937 |
7 | FGFR4 | 2.57765746 |
8 | GRK7 | 2.53524661 |
9 | TYK2 | 2.48285235 |
10 | CAMK1D | 2.43869061 |
11 | INSRR | 2.29579888 |
12 | ACVR1B | 2.27018172 |
13 | DDR2 | 1.92273401 |
14 | TIE1 | 1.82429935 |
15 | CAMK1G | 1.81604714 |
16 | CDC42BPA | 1.80918963 |
17 | PKN2 | 1.72149708 |
18 | PRPF4B | 1.63837866 |
19 | JAK1 | 1.58855000 |
20 | MAPK12 | 1.55090281 |
21 | NEK9 | 1.53684675 |
22 | TAOK3 | 1.53435375 |
23 | FGR | 1.47877576 |
24 | PIK3CG | 1.47139365 |
25 | IRAK3 | 1.42699594 |
26 | TBK1 | 1.42486720 |
27 | PDK2 | 1.41622172 |
28 | MAP2K3 | 1.37934363 |
29 | KDR | 1.36213285 |
30 | TRIB3 | 1.34533092 |
31 | MAP3K11 | 1.33714969 |
32 | JAK2 | 1.30982080 |
33 | PTK6 | 1.28986385 |
34 | JAK3 | 1.26031917 |
35 | PRKAA2 | 1.25776994 |
36 | BLK | 1.24190712 |
37 | MAP2K4 | 1.22216880 |
38 | EPHA3 | 1.17760578 |
39 | EPHB1 | 1.15195743 |
40 | CSK | 1.12172626 |
41 | MAPK11 | 1.12059832 |
42 | MAPK7 | 1.08097227 |
43 | MAP3K1 | 1.05306922 |
44 | MST1R | 1.01564355 |
45 | SYK | 0.97272797 |
46 | PAK4 | 0.94660834 |
47 | FLT3 | 0.93986137 |
48 | PRKG2 | 0.91376332 |
49 | TSSK6 | 0.89995586 |
50 | MAP3K3 | 0.89905949 |
51 | PDGFRA | 0.89728415 |
52 | ERBB4 | 0.89571229 |
53 | MAP3K10 | 0.88488307 |
54 | NME2 | 0.86921058 |
55 | CDK6 | 0.84742244 |
56 | MAP3K7 | 0.83696130 |
57 | FGFR2 | 0.81655971 |
58 | MAP3K14 | 0.79552590 |
59 | CAMK4 | 0.78706234 |
60 | EPHB2 | 0.77984777 |
61 | GSK3A | 0.77697980 |
62 | MAPK4 | 0.77633975 |
63 | MAP4K1 | 0.77148042 |
64 | FRK | 0.76234478 |
65 | IGF1R | 0.74941025 |
66 | ITK | 0.74040973 |
67 | ZAP70 | 0.73526098 |
68 | PDPK1 | 0.73396676 |
69 | PDK1 | 0.70803356 |
70 | RIPK1 | 0.69423383 |
71 | STK10 | 0.67701721 |
72 | TNK2 | 0.66332839 |
73 | MAP3K2 | 0.65762188 |
74 | PAK2 | 0.65469614 |
75 | MOS | 0.63499412 |
76 | TAOK2 | 0.63067617 |
77 | DAPK2 | 0.63048125 |
78 | ICK | 0.63029253 |
79 | HCK | 0.62030545 |
80 | LATS1 | 0.61989374 |
81 | TAOK1 | 0.61795087 |
82 | MATK | 0.61748035 |
83 | RPS6KA2 | 0.60640812 |
84 | KSR2 | 0.58295940 |
85 | PRKCZ | 0.55785249 |
86 | MARK2 | 0.54332738 |
87 | GRK1 | 0.53993979 |
88 | MAP3K6 | 0.53031677 |
89 | TESK2 | 0.52417089 |
90 | PDGFRB | 0.52355265 |
91 | CAMKK1 | 0.52028878 |
92 | MAP2K2 | 0.51638913 |
93 | SGK3 | 0.50936248 |
94 | PKN1 | 0.50725863 |
95 | GRK5 | 0.49349745 |
96 | TGFBR1 | 0.48802500 |
97 | LYN | 0.48576448 |
98 | TYRO3 | 0.48496081 |
99 | PRKAA1 | 0.48386489 |
100 | ERBB2 | 0.47650732 |
101 | NTRK3 | 0.47170567 |
102 | PINK1 | 0.46690498 |
103 | FGFR3 | 0.46296709 |
104 | MAP2K6 | 0.44699515 |
105 | IKBKE | 0.44639614 |
106 | PRKACG | 0.44243657 |
107 | EGFR | 0.44046833 |
108 | RET | 0.43841905 |
109 | FYN | 0.43660288 |
110 | ABL2 | 0.43567787 |
111 | IKBKB | 0.43513812 |
112 | MAPKAPK3 | 0.43201191 |
113 | TESK1 | 0.42872274 |
114 | IRAK4 | 0.42443194 |
115 | SRC | 0.41468461 |
116 | RIPK4 | 0.40659666 |
117 | PRKD1 | 0.40621524 |
118 | ABL1 | 0.39673167 |
119 | PIM2 | 0.39122790 |
120 | FER | 0.38607410 |
121 | FES | 0.38571038 |
122 | KIT | 0.38159699 |
123 | PRKG1 | 0.37383508 |
124 | RPS6KL1 | 0.37201131 |
125 | RPS6KC1 | 0.37201131 |
126 | MAP3K13 | 0.36078302 |
127 | ADRBK2 | 0.35908112 |
128 | INSR | 0.34345129 |
129 | EEF2K | 0.33556767 |
130 | CDK3 | 0.33253265 |
131 | STK11 | 0.31397107 |
132 | LCK | 0.30700955 |
133 | SIK2 | 0.30575208 |
134 | CAMKK2 | 0.29423207 |
135 | PTK2B | 0.28928907 |
136 | IRAK2 | 0.28439241 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.34385588 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.97085401 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.21240883 |
4 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.13216494 |
5 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.09174314 |
6 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.00586242 |
7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.97488426 |
8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.56722828 |
9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.52795667 |
10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.41702644 |
11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.33162584 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.26729030 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.24012376 |
14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.14598729 |
15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.08951902 |
16 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.02211665 |
17 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.91526384 |
18 | Peroxisome_Homo sapiens_hsa04146 | 1.90818315 |
19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.86219683 |
20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.85299843 |
21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.83205762 |
22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.81366808 |
23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.78636361 |
24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.76071195 |
25 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.74332772 |
26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.62337472 |
27 | Bile secretion_Homo sapiens_hsa04976 | 1.56788974 |
28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.54928977 |
29 | ABC transporters_Homo sapiens_hsa02010 | 1.53828630 |
30 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.52135912 |
31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.49545352 |
32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.43988104 |
33 | Asthma_Homo sapiens_hsa05310 | 1.39576495 |
34 | Mineral absorption_Homo sapiens_hsa04978 | 1.37795497 |
35 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.35209275 |
36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.34864946 |
37 | Phagosome_Homo sapiens_hsa04145 | 1.31139806 |
38 | Tuberculosis_Homo sapiens_hsa05152 | 1.28180317 |
39 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.26468912 |
40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.25248341 |
41 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.22944603 |
42 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.22099431 |
43 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.22035804 |
44 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.15015218 |
45 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.14054032 |
46 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.11779502 |
47 | Allograft rejection_Homo sapiens_hsa05330 | 1.10616638 |
48 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.09792654 |
49 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.06886714 |
50 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.04905839 |
51 | Prion diseases_Homo sapiens_hsa05020 | 0.98904827 |
52 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.96832283 |
53 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.96394802 |
54 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.95663188 |
55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.95614260 |
56 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.91016652 |
57 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.88900661 |
58 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.87431991 |
59 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86366107 |
60 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.85317589 |
61 | Lysine degradation_Homo sapiens_hsa00310 | 0.85189763 |
62 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.85009429 |
63 | Carbon metabolism_Homo sapiens_hsa01200 | 0.83737569 |
64 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.83453893 |
65 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.81404380 |
66 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.77438593 |
67 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.76674000 |
68 | Other glycan degradation_Homo sapiens_hsa00511 | 0.76388098 |
69 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.75414957 |
70 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.73803113 |
71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.72517097 |
72 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.72415246 |
73 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.70633967 |
74 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.70472294 |
75 | Malaria_Homo sapiens_hsa05144 | 0.69147204 |
76 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.68871520 |
77 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.68726267 |
78 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.67350348 |
79 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.66869979 |
80 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.66147230 |
81 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.65029029 |
82 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.58364288 |
83 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.55579526 |
84 | Sulfur relay system_Homo sapiens_hsa04122 | 0.55168516 |
85 | Amoebiasis_Homo sapiens_hsa05146 | 0.52763333 |
86 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.52035948 |
87 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.47389484 |
88 | Lysosome_Homo sapiens_hsa04142 | 0.44968037 |
89 | Salmonella infection_Homo sapiens_hsa05132 | 0.44377839 |
90 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.44258526 |
91 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.43774275 |
92 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.42565764 |
93 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.40777906 |
94 | Insulin resistance_Homo sapiens_hsa04931 | 0.39015450 |
95 | Influenza A_Homo sapiens_hsa05164 | 0.38293064 |
96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.34222810 |
97 | Viral myocarditis_Homo sapiens_hsa05416 | 0.33894716 |
98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.33130599 |
99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.32823853 |
100 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.32192110 |
101 | Pertussis_Homo sapiens_hsa05133 | 0.31645064 |
102 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.31531661 |
103 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.30642146 |
104 | Platelet activation_Homo sapiens_hsa04611 | 0.30588007 |
105 | Metabolic pathways_Homo sapiens_hsa01100 | 0.27992264 |
106 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.27456361 |
107 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.27249989 |
108 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.26087643 |
109 | Renin secretion_Homo sapiens_hsa04924 | 0.24838583 |
110 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.24229315 |
111 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.21685554 |
112 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.17548179 |
113 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.17152750 |
114 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.15073190 |
115 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.13047253 |
116 | Galactose metabolism_Homo sapiens_hsa00052 | 0.12064547 |
117 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.09308187 |
118 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08287318 |
119 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.06110939 |
120 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.04999815 |
121 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.03641946 |
122 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.01895999 |
123 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.01584162 |
124 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.01323182 |
125 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0902551 |
126 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | -0.0725538 |
127 | Leishmaniasis_Homo sapiens_hsa05140 | -0.0650030 |
128 | Legionellosis_Homo sapiens_hsa05134 | -0.0630787 |
129 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0508755 |
130 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0373027 |
131 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.0147271 |
132 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.0041322 |
133 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0017924 |